Report Detail
Global Pneumococcal Vaccine Polyvalent Market Insights, Forecast to 2025
- RnM3521256 |
- 14 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.
The global Pneumococcal Vaccine Polyvalent market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pneumococcal Vaccine Polyvalent market based on company, product type, end user and key regions.
This report studies the global market size of Pneumococcal Vaccine Polyvalent in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Vaccine Polyvalent in these regions.
This research report categorizes the global Pneumococcal Vaccine Polyvalent market by top players/brands, region, type and end user. This report also studies the global Pneumococcal Vaccine Polyvalent market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co.
Pfizer
Market size by Product
Prevnar 13
Pneumovax23
Market size by End User
18 years and younger
19 to 64 years old
65 years and older
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pneumococcal Vaccine Polyvalent market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pneumococcal Vaccine Polyvalent market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pneumococcal Vaccine Polyvalent companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pneumococcal Vaccine Polyvalent submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pneumococcal Vaccine Polyvalent are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Vaccine Polyvalent market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Pneumococcal Vaccine Polyvalent Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Pneumococcal Vaccine Polyvalent Market Size Growth Rate by Product
- 1.4.2 Prevnar 13
- 1.4.3 Pneumovax23
- 1.5 Market by End User
- 1.5.1 Global Pneumococcal Vaccine Polyvalent Market Size Growth Rate by End User
- 1.5.2 18 years and younger
- 1.5.3 19 to 64 years old
- 1.5.4 65 years and older
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pneumococcal Vaccine Polyvalent Market Size
- 2.1.1 Global Pneumococcal Vaccine Polyvalent Revenue 2014-2025
- 2.1.2 Global Pneumococcal Vaccine Polyvalent Sales 2014-2025
- 2.2 Pneumococcal Vaccine Polyvalent Growth Rate by Regions
- 2.2.1 Global Pneumococcal Vaccine Polyvalent Sales by Regions
- 2.2.2 Global Pneumococcal Vaccine Polyvalent Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Pneumococcal Vaccine Polyvalent Sales by Manufacturers
- 3.1.1 Pneumococcal Vaccine Polyvalent Sales by Manufacturers
- 3.1.2 Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers
- 3.1.3 Global Pneumococcal Vaccine Polyvalent Market Concentration Ratio (CR5 and HHI)
- 3.2 Pneumococcal Vaccine Polyvalent Revenue by Manufacturers
- 3.2.1 Pneumococcal Vaccine Polyvalent Revenue by Manufacturers (2014-2019)
- 3.2.2 Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers (2014-2019)
- 3.3 Pneumococcal Vaccine Polyvalent Price by Manufacturers
- 3.4 Pneumococcal Vaccine Polyvalent Manufacturing Base Distribution, Product Types
- 3.4.1 Pneumococcal Vaccine Polyvalent Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pneumococcal Vaccine Polyvalent Product Type
- 3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccine Polyvalent Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Pneumococcal Vaccine Polyvalent Sales by Product
- 4.2 Global Pneumococcal Vaccine Polyvalent Revenue by Product
- 4.3 Pneumococcal Vaccine Polyvalent Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Pneumococcal Vaccine Polyvalent Breakdown Data by End User
6 North America
- 6.1 North America Pneumococcal Vaccine Polyvalent by Countries
- 6.1.1 North America Pneumococcal Vaccine Polyvalent Sales by Countries
- 6.1.2 North America Pneumococcal Vaccine Polyvalent Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Pneumococcal Vaccine Polyvalent by Product
- 6.3 North America Pneumococcal Vaccine Polyvalent by End User
7 Europe
- 7.1 Europe Pneumococcal Vaccine Polyvalent by Countries
- 7.1.1 Europe Pneumococcal Vaccine Polyvalent Sales by Countries
- 7.1.2 Europe Pneumococcal Vaccine Polyvalent Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pneumococcal Vaccine Polyvalent by Product
- 7.3 Europe Pneumococcal Vaccine Polyvalent by End User
8 Asia Pacific
- 8.1 Asia Pacific Pneumococcal Vaccine Polyvalent by Countries
- 8.1.1 Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Countries
- 8.1.2 Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Pneumococcal Vaccine Polyvalent by Product
- 8.3 Asia Pacific Pneumococcal Vaccine Polyvalent by End User
9 Central & South America
- 9.1 Central & South America Pneumococcal Vaccine Polyvalent by Countries
- 9.1.1 Central & South America Pneumococcal Vaccine Polyvalent Sales by Countries
- 9.1.2 Central & South America Pneumococcal Vaccine Polyvalent Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Pneumococcal Vaccine Polyvalent by Product
- 9.3 Central & South America Pneumococcal Vaccine Polyvalent by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Pneumococcal Vaccine Polyvalent by Countries
- 10.1.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Countries
- 10.1.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Pneumococcal Vaccine Polyvalent by Product
- 10.3 Middle East and Africa Pneumococcal Vaccine Polyvalent by End User
11 Company Profiles
- 11.1 Merck & Co.
- 11.1.1 Merck & Co. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Products Offered
- 11.1.5 Merck & Co. Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Pneumococcal Vaccine Polyvalent Products Offered
- 11.2.5 Pfizer Recent Development
12 Future Forecast
- 12.1 Pneumococcal Vaccine Polyvalent Market Forecast by Regions
- 12.1.1 Global Pneumococcal Vaccine Polyvalent Sales Forecast by Regions 2019-2025
- 12.1.2 Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Regions 2019-2025
- 12.2 Pneumococcal Vaccine Polyvalent Market Forecast by Product
- 12.2.1 Global Pneumococcal Vaccine Polyvalent Sales Forecast by Product 2019-2025
- 12.2.2 Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Product 2019-2025
- 12.3 Pneumococcal Vaccine Polyvalent Market Forecast by End User
- 12.4 North America Pneumococcal Vaccine Polyvalent Forecast
- 12.5 Europe Pneumococcal Vaccine Polyvalent Forecast
- 12.6 Asia Pacific Pneumococcal Vaccine Polyvalent Forecast
- 12.7 Central & South America Pneumococcal Vaccine Polyvalent Forecast
- 12.8 Middle East and Africa Pneumococcal Vaccine Polyvalent Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pneumococcal Vaccine Polyvalent Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pneumococcal Vaccine Polyvalent. Industry analysis & Market Report on Pneumococcal Vaccine Polyvalent is a syndicated market report, published as Global Pneumococcal Vaccine Polyvalent Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pneumococcal Vaccine Polyvalent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
